Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
SB-913-1603: A Phase I, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-913, a rAAV2/6-based Gene Transfer in Subjects with Mucopolysaccharidosis II (MPS II)
Alden, Tord D
(PD/PI)
Burton, Barbara K
(PD/PI)
Mohammad, Saeed
(PD/PI)
Neurological Surgery
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
9/1/17
→
8/31/50
Funding
Sangamo Therapeutics, Inc.
View all
View less